“…Furthermore, hypocretin-1 induces c-Fos expression in the PVN (Ida et al, 2000a) and dose dependently stimulates ACTH and corticosterone release (Hagan et al, 1999;Ida et al, 2000a;Jaszberenyi et al, 2000;Kuru et al, 2000;Samson et al, 2002). Pretreatment with ␣-helical CRF, a CRF antagonist, blocks the corticosterone elevation induced by hcrt (Ida et al, 2000b;Jaszberenyi et al, 2000;Samson et al, 2002). Hypocretindeficient narcoleptic patients have a lower basal ACTH release, suggesting reduced CRF tonus, although cortisol secretion did not differ from that of controls (Kok et al, 2002).…”